The disclosure provides genetically engineered microorganisms capable of producing antigen-binding molecules. Additionally, the disclosure provides engineered microorganisms comprising one or more disrupted genes to strategically divert carbon flux away from undesirable products towards products, and optionally co-products, of interest. Further, the disclosure enables co-production of useful chemicals from gaseous substrates.

Disclosed are novel nitrilated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a nitrile-group containing compound.

The technology provided herein relates to novel methods for producing lactic acid (L-lactic acid, D-lactic acid and D/L-Lactic acid) from starch containing material with extreme thermophilic bacterial cells belonging to the genus Caldicellulosiruptor, mutants thereof, isolated strains, microbial cultures, and microbial compositions. The novel methods are in particular suitable for the production of lactic acid from any carbon source, not limited to but especially useful for unmodified starch and/or starch-containing material.

Provided are ribulose-phosphate 3-epimerase, a microorganism and a composition, each including the ribulose-phosphate 3-epimerase, and a method of producing psicose-6-phosphate or psicose using the same.

The present invention relates to a composition comprising bacteria of the Delftia genus, specifically a composition comprising Delftia tsuruhatensis as well as the bacteria itself for use in the prevention of malaria transmission and methods of using the compositions for reducing malaria and/or malaria parasite transmission.

A method of preparing ammonium sulfate includes feeding biosulfur and ammonia produced during anaerobic fermentation into a sulfur-oxidizing microbial reactor to cause sulfur-oxidizing microorganisms to produce sulfuric acid through oxidation of the biosulfur and reacting the produced sulfuric acid with ammonia to produce the ammonium sulfate. A culture medium containing the produced ammonium sulfate and microorganisms can be used as fertilizers.

A method for producing PHA polymer includes using bacteria in which the bacteria are grown under heterotrophic conditions using an organic substance as carbon source and exponential growth conditions. The bacteria are then cultivated under autotrophic conditions under an atmosphere of H.sub.2, CO.sub.2 and O.sub.2, wherein the O.sub.2 content is less than 10% (v/v) and the pressure is more than 1 barg.

The present application refers to oral compositions comprising an effective amount of a Pediococcus acidilactici strain for use in regulating blood glucose levels, as well as for the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition. The application also refers to Pediococcus acidilactici CECT 9879, Pediococcus acidilactici CECT 9889 and Pediococcus acidilactici CECT 9967, and to these strains for use as probiotics, medicaments and for regulating blood glucose levels, as well as for the prevention and/or treatment of hyperglycemia and/or a hyperglycemia-related condition.

This invention concerns a process to identify consortia of probiotic strains belonging to e.g. the genera Lactobacillus, Bacillus, Pediococcus, and Weissella that can be used in preparations for food supplement, food production, and pharmaceutical applications with the intention to execute a safe and rapid degradation of gluten to non-toxic, non-immunogenic digests.

The present invention provides a microbial consortium comprising two or more microorganisms, compositions and kits comprising the same and uses thereof in methods of treating immune-related conditions.